» Articles » PMID: 32393187

Detrimental Role of Sphingosine Kinase 1 in Kidney Damage in DOCA-salt Hypertensive Model: Evidence from Knockout Mice

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2020 May 13
PMID 32393187
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingolipids and produced by sphingosine kinases (SphK1 and SphK2). SphK1/S1P pathway is implicated in the progression of chronic kidney disease. However, the role of SphK1/S1P pathway in renal injury in hypertension has not been reported. This study tested the hypothesis that SphK1/S1P pathway mediates the kidney damage in DOCA-salt hypertensive mice.

Methods: Male wild type (WT) C57BL6 and SphK1 knockout (KO) mice were subjected to unilateral nephrectomy, subcutaneous implant containing 50 mg of deoxycorticosterone acetate (DOCA) and 1% NaCl drinking water for 7 weeks. At the end of experiments, blood pressure data, 24 h urine and kidney samples were collected. Renal mRNA levels of SphK1 were measured by real-time RT-PCR. Markers for fibrogenesis and immune cell infiltration in kidneys were detected using Western blot and immunohistochemistray analysis, respectively. The glomerular morphological changes were examined in kidney tissue slides stained with Periodic-Acid Schiff. Four groups were studied: wild type control (WT-C), WT-DOCA, KO-C and KO-DOCA.

Results: The renal SphK1 mRNA expression was significantly upregulated in WT-DOCA mice, whereas this upregulation of renal SphK1 mRNA was blocked in KO-DOCA mice. There was no difference in DOCA-salt-induced hypertension between WT and KO mice. The urinary albumin was increased in both DOCA-salt groups. However, the albuminuria was significantly lower in KO-DOCA than in WT-DOCA group. There were increases in glomerulosclerosis indices in both DOCA-salt groups, whereas the increases were also significantly lower in KO-DOCA than in WT-DOCA mice. Renal protein levels of α-smooth muscle actin were upregulated in both DOCA-salt groups, but the increase was significant lower in KO-DOCA than in WT-DOCA group. The increased staining areas of collagen detected by Sirius Red-staining in kidney tissue sections were also attenuated in KO-DOCA compared with WT-DOCA mice. In contrast, the increased infiltration of CD43+ (a T cell marker) or CD68+ (a macrophage marker) cells in DOCA-salt kidneys showed no significant difference between WT-DOCA and KO-DOCA mice.

Conclusions: SphK1/S1P signaling pathway mediates kidney damage in DOCA-salt hypertensive mice independent of blood pressure and immune modulation.

Citing Articles

Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney disease.

Jones B, Myakala K, Guha M, Davidson S, Adapa S, Lopez Santiago I Am J Physiol Renal Physiol. 2023; 325(6):F792-F810.

PMID: 37823198 PMC: 10894665. DOI: 10.1152/ajprenal.00292.2023.


Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.

Hu G, Xie D, Chen C, Wang W, Li P, Ritter J Am J Hypertens. 2023; 36(9):509-516.

PMID: 37171128 PMC: 10403973. DOI: 10.1093/ajh/hpad046.


Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice.

Chen C, Wang W, Raymond M, Ahmadinejad F, Poklis J, Em B Mol Pharmacol. 2023; 103(4):230-240.

PMID: 36702548 PMC: 10029825. DOI: 10.1124/molpharm.122.000618.


Nephrotoxicity in cancer treatment: An update.

Chen C, Xie D, Gewirtz D, Li N Adv Cancer Res. 2022; 155:77-129.

PMID: 35779877 PMC: 11017963. DOI: 10.1016/bs.acr.2022.03.005.


Inactivation of fatty acid amide hydrolase protects against ischemic reperfusion injury-induced renal fibrogenesis.

Chen C, Wang W, Poklis J, Lichtman A, Ritter J, Hu G Biochim Biophys Acta Mol Basis Dis. 2022; 1868(10):166456.

PMID: 35710061 PMC: 10215004. DOI: 10.1016/j.bbadis.2022.166456.

References
1.
Maceyka M, Spiegel S . Sphingolipid metabolites in inflammatory disease. Nature. 2014; 510(7503):58-67. PMC: 4320971. DOI: 10.1038/nature13475. View

2.
Park S, Kim M, Kim M, DAgati V, Lee H . Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. Kidney Int. 2011; 80(12):1315-27. DOI: 10.1038/ki.2011.281. View

3.
Han W, Zhu Q, Hu J, Li P, Zhang F, Li N . Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Biochim Biophys Acta. 2013; 1833(6):1454-62. PMC: 3631109. DOI: 10.1016/j.bbamcr.2013.02.029. View

4.
Chi H . Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol Sci. 2010; 32(1):16-24. PMC: 3017656. DOI: 10.1016/j.tips.2010.11.002. View

5.
Zhang X, Ritter J, Li N . Sphingosine-1-phosphate pathway in renal fibrosis. Am J Physiol Renal Physiol. 2018; 315(4):F752-F756. PMC: 6230725. DOI: 10.1152/ajprenal.00596.2017. View